NO20021000L - Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT) - Google Patents

Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT)

Info

Publication number
NO20021000L
NO20021000L NO20021000A NO20021000A NO20021000L NO 20021000 L NO20021000 L NO 20021000L NO 20021000 A NO20021000 A NO 20021000A NO 20021000 A NO20021000 A NO 20021000A NO 20021000 L NO20021000 L NO 20021000L
Authority
NO
Norway
Prior art keywords
mesoprogestins
hrt
preparations
component
replacement therapy
Prior art date
Application number
NO20021000A
Other languages
English (en)
Other versions
NO20021000D0 (no
Inventor
Walter Elger
Kristof Chwalisz
Gerd Schubert
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20021000D0 publication Critical patent/NO20021000D0/no
Publication of NO20021000L publication Critical patent/NO20021000L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021000A 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT) NO20021000L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38614099A 1999-08-31 1999-08-31
PCT/US2000/023771 WO2001034126A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)

Publications (2)

Publication Number Publication Date
NO20021000D0 NO20021000D0 (no) 2002-02-28
NO20021000L true NO20021000L (no) 2002-03-14

Family

ID=23524333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021000A NO20021000L (no) 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT)

Country Status (33)

Country Link
EP (1) EP1605924B1 (no)
JP (1) JP2003513908A (no)
KR (1) KR100729311B1 (no)
CN (1) CN1454088A (no)
AR (1) AR025456A1 (no)
AT (1) ATE413168T1 (no)
AU (1) AU781836B2 (no)
BG (1) BG65846B1 (no)
BR (1) BR0013710A (no)
CA (1) CA2383659C (no)
CO (1) CO5200773A1 (no)
CZ (1) CZ301412B6 (no)
DE (1) DE60040764D1 (no)
EA (1) EA007840B1 (no)
EE (1) EE200200102A (no)
ES (1) ES2316402T3 (no)
HR (1) HRP20020266A2 (no)
HU (1) HUP0202460A3 (no)
IL (2) IL148417A0 (no)
LT (1) LT5011B (no)
LV (1) LV12942B (no)
MX (1) MXPA02002190A (no)
NO (1) NO20021000L (no)
NZ (1) NZ517469A (no)
PE (1) PE20010581A1 (no)
PL (1) PL198798B1 (no)
RO (1) RO122180B1 (no)
RS (1) RS50396B (no)
SI (1) SI20851B (no)
SK (1) SK287121B6 (no)
UA (1) UA75339C2 (no)
WO (1) WO2001034126A2 (no)
ZA (1) ZA200201621B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1525215B1 (de) * 2002-08-02 2006-09-06 Schering Aktiengesellschaft Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
RU2611370C1 (ru) * 2016-01-12 2017-02-21 Общество с ограниченной ответственностью Медицинская Корпорация "РАНА" Применение препарата Лаеннек для уменьшения или устранения проявления менопаузальных симптомов (варианты)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
DE4225623C2 (de) * 1992-08-03 1994-06-30 Karl Hehl Verfahren zur Herstellung einer pulverförmigen Spritzgußmasse für die Herstellung von Porzellan und deren Verwendung
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
CA2203541A1 (en) * 1994-10-24 1996-05-02 Kristof Chwalisz Competitive progesterone antagonists for demand-oriented female birth control
DE19610635A1 (de) * 1996-03-11 1997-09-18 Schering Ag Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
WO1997049407A1 (en) * 1996-06-25 1997-12-31 Akzo Nobel N.V. Progestogen-anti-progestogen regimens
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
TR200102041T2 (tr) * 1999-01-14 2001-12-21 Bayer Corporation Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar

Also Published As

Publication number Publication date
LT2002037A (en) 2002-11-25
HUP0202460A3 (en) 2004-04-28
NZ517469A (en) 2004-01-30
WO2001034126A3 (en) 2001-11-22
CZ2002706A3 (cs) 2002-10-16
EP1605924A2 (en) 2005-12-21
CZ301412B6 (cs) 2010-02-24
IL148417A (en) 2010-11-30
BG106443A (bg) 2002-09-30
HUP0202460A2 (hu) 2002-12-28
BR0013710A (pt) 2002-05-07
EP1605924B1 (en) 2008-11-05
LV12942B (en) 2003-06-20
KR20020027618A (ko) 2002-04-13
SK287121B6 (sk) 2009-12-07
PL198798B1 (pl) 2008-07-31
WO2001034126A2 (en) 2001-05-17
RO122180B1 (ro) 2009-02-27
WO2001034126A9 (en) 2002-09-12
CA2383659A1 (en) 2001-05-17
SK2972002A3 (en) 2002-07-02
SI20851A (sl) 2002-10-31
PE20010581A1 (es) 2001-06-04
ZA200201621B (en) 2004-08-25
AR025456A1 (es) 2002-11-27
IL148417A0 (en) 2002-09-12
NO20021000D0 (no) 2002-02-28
PL353931A1 (en) 2003-12-15
CN1454088A (zh) 2003-11-05
EA200200285A1 (ru) 2002-08-29
BG65846B1 (bg) 2010-03-31
AU781836B2 (en) 2005-06-16
AU3633201A (en) 2001-06-06
DE60040764D1 (de) 2008-12-18
RS50396B (sr) 2009-12-31
JP2003513908A (ja) 2003-04-15
ATE413168T1 (de) 2008-11-15
UA75339C2 (en) 2006-04-17
HRP20020266A2 (en) 2004-08-31
ES2316402T3 (es) 2009-04-16
MXPA02002190A (es) 2002-09-30
EA007840B1 (ru) 2007-02-27
EE200200102A (et) 2003-04-15
LT5011B (lt) 2003-04-25
CO5200773A1 (es) 2002-09-27
SI20851B (sl) 2009-06-30
YU14102A (sh) 2006-01-16
KR100729311B1 (ko) 2007-06-19
CA2383659C (en) 2009-02-10

Similar Documents

Publication Publication Date Title
AU2003230581A1 (en) Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
DK1208095T3 (da) Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetes
EE200100567A (et) Glükokortikoidretseptori modulaatorid
ATE432257T1 (de) Tricyclische steroidhormonkernrezeptor- modulatoren
AU4557099A (en) Novel therapeutic agents that modulate estrogen receptors
HUP0200416A3 (en) Pharmaceutical composition useful for low dose estrogen interrupted hormone replacement therapy
EE200100053A (et) Biogeensete östrogeensulfamaatide kasutamine hormoonasendusraviks
NO20021000D0 (no) Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT)
AU5869100A (en) Melanin concentrating hormone receptor
EE200200103A (et) Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina
IS2702B (is) Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun
NO20015378L (no) Cyklokarbamatderivater som progesteronreseptormodulatorer
NO20032415L (no) Forbindelser som er aktive på glukokortikoidreseptor II
AU2002353076A1 (en) Antisense modulation of estrogen receptor beta expression
AU8146398A (en) Coup-tfii: an orphan nuclear receptor required for angiogenesis
AU4838500A (en) High throughput assay for modulators of nuclear receptors
HK1043789A1 (zh) 作為黃體酮受體調節劑的環硫代胺基甲酸鹽衍生物
AU2003206424A1 (en) Sequential estrogen/progesterone antagonist combination for hormone replacement therapy
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
AU2002356588A1 (en) TRANSDERMAL THERAPEUTICAL SYSTEM FOR THE ADMINISTRATION OF 17Alpha ESTRADIOL
DK1178806T3 (da) Transdermal indretning til administration af testosteron eller derivater deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application